Novavax shares soar on license deal with Sanofi at lofty valuation

Published on 10 May 2024 on Reuters via AOL

(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with ...

Read the rest of the article

Start tracking your investments with Statfolio

FILES-CANADA-HEALTH-VIRUS-VACCINES Everyone loves a comeback story: the underdog fighting back fo...

Financial Post via Yahoo Finance 30 May 2024

Amidst a backdrop of mixed performances across global markets, France's CAC 40 Index saw a modest...

Simply Wall St. via Yahoo Finance 30 May 2024

Shares of Insmed INSM more than doubled in market value on Tuesday after reporting positive topli...

Zacks via Yahoo Finance 29 May 2024

Johnson & Johnson JNJ announced a definitive agreement with Swiss biotech Numab Therapeutics to a...

Zacks via Yahoo Finance 29 May 2024

In recent trading sessions, France's CAC 40 Index has experienced a modest decline of 0.89%, refl...

Simply Wall St. via Yahoo Finance 29 May 2024

Sanofi SNY announced that the FDA has accepted the supplemental biologics license application (sB...

Zacks via Yahoo Finance 27 May 2024

The stock market has performed relatively well since the beginning of the year although, of cours...

The Motley Fool 25 May 2024

Novavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...

Yahoo Finance via AOL 10 May 2024

Novavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares h...

InvestorPlace 10 May 2024

(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with...

Reuters via AOL 10 May 2024